SCHEMBL6330271

SCHEMBL6330271

CCCn1c(C)c(C(=O)c2cccc3cc(OC)ccc23)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 20/20 1.00
CNR1 P21554 7/20 0.76
CYP1A2 P05177 2/20 0.76
HPGD P15428 2/20 0.76
TSHR P16473 2/20 0.76
MAPK1 P28482 2/20 0.76
CYP2C19 P33261 2/20 0.76
MEN1 O00255 1/20 0.76
NR1I2 O75469 1/20 0.76
ALDH1A1 P00352 1/20 0.76
MAPT P10636 1/20 0.76
KMT2A Q03164 1/20 0.76
NR1H4 Q96RI1 1/20 0.76
SLC6A3 Q01959 1/20 0.65
GMNN O75496 1/20 0.61
LMNA P02545 1/20 0.61
CYP3A4 P08684 1/20 0.61
ALOX15 P16050 1/20 0.61
NFKB1 P19838 1/20 0.61
THPO P40225 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29989064 1.00 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL29989370 0.93 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL6328023 0.93 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL6333260 0.92 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL29988969 0.92 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL497044 0.87 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL29988870 0.85 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL6325579 0.85 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL29989324 0.81 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR
SCHEMBL6324281 0.81 CNR2 (1.00) CNR2CNR1CYP1A2HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009903-A1 CB2-selective cannabinoid analogues CLEMSON UNIVERSITY 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009903-A1 CB2-selective cannabinoid analogues CNR2, CNR1, GPR68 CNR2 1/4885CNR1 2/4885CYP1A2 825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.